NCT06316206View on ClinicalTrials.gov

The Use of Ethinylestradiol/Dienogest in Random Start Rapid Endometrial Preparation

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 1, 2023

Study Completion Date

March 1, 2024

Conditions
Endometrial PolypEndometrial Diseases
Interventions
DRUG

Ethinylestradiol/Dienogest 0.03mg/2mg

Endometrial polyps underwent hysteroscopic polipectomy after starting 14-day treatment with oral Ethinylestradiol/Dienogest 0.03mg/2mg at any time of the menstrual cycle

Trial Locations (2)

90123

Andrea Etrusco, Palermo

00161

Marco Monti, Roma

All Listed Sponsors
collaborator

University of Roma La Sapienza

OTHER

lead

University of Palermo

OTHER